13.2 Monitored Exercise Testing

Monitored Exercise Testing on the RPFT Blueprint

Field walking (13.1) is self- or audio-paced corridor work. Monitored exercise testing adds controlled external workload (treadmill or cycle) plus intensified physiologic monitoring. On the NBRC PFT DCO this maps to II.A.13.b (select), II.B.13.b (perform), and II.C.13.b (evaluate validity).

Exam stems mix three layers:

1. Mode and protocol selection (why treadmill vs cycle; incremental vs steady-state concepts)
2. Safe performance (what you watch; when you stop)
3. Scope (what a PFT technologist executes vs what a full CPET lab reports)

Domain I equipment knowledge (calibrated treadmill speed/grade, ergometer watts, ECG signal quality) is assumed; this section focuses on procedure.

Indications and Selection (II.A.13.b)

Orders vary by institution. Common clinical reasons to select monitored exercise include:

Do not select maximal monitored exercise when absolute contraindications exist (unstable angina, uncontrolled arrhythmia, acute illness, severe symptomatic aortic stenosis as defined by policy, acute decompensated heart failure, etc.). Relative contraindications and “modify or defer” decisions follow written medical direction—not technologist improvisation.

Modes: Treadmill vs Cycle Ergometer

Selection pearls:

• Prefer cycle when balance is poor, treadmill is frightening, or orthopedic pain makes walking unsafe.
• Prefer treadmill when the clinical question is walking capacity or when the lab’s standard protocol is treadmill-based and the patient can walk safely.
• Keep mode constant for serial comparisons when possible—switching treadmill ↔ cycle changes peak work and HR responses.

Holding the treadmill handrails tightly reduces effective work and can inflate “exercise tolerance” on paper—coach light touch for balance only unless safety requires support (then document).

Incremental Protocols Overview

An incremental (graded) protocol raises external work in stages until a stopping point:

1. Rest / baseline monitoring
2. Warm-up at low work (optional but common)
3. Stages of increasing speed/grade (treadmill) or watts (cycle), each lasting a fixed time (e.g., 1–3 minutes depending on protocol)
4. Peak / symptom-limited endpoint or target endpoint defined by order
5. Recovery monitoring (cool-down + seated/standing recovery per SOP)

You do not need to memorize every brand-name treadmill protocol for the RPFT, but you must know the concepts:

• Workload must be known and calibrated (Domain I carry-forward): wrong speed/grade or uncalibrated ergometer invalidates the stage table.
• Stage duration must be long enough for near–steady measurements (BP, SpO2, symptoms) at that stage when the protocol requires them.
• Ramp protocols increase work continuously or in small frequent steps; step protocols use discrete stages—both are “incremental” in the broad sense.
• Constant-work (steady-state) tests hold one workload—used for endurance or specific desaturation checks; do not label them as peak incremental tests on the report.

Targets and endpoints (high-level)

Depending on order and policy, endpoints may include:

• Patient symptom limit (severe dyspnea, leg fatigue, chest pain)
• Achievement of a target heart rate range (if used—know limitations in β-blocked patients)
• Protocol completion of a prescribed stage set
• Meeting a stop criterion (absolute or relative)

Always clarify whether the test is symptom-limited maximal, submaximal, or titration-focused before starting.

Monitoring During Exercise (II.B.13.b)

Performance sequence (concept):

1. Verify emergency equipment readiness and medical coverage pathway per lab policy.
2. Explain the test, stop rules, and how to signal distress.
3. Prep skin and apply ECG electrodes if used; confirm readable baseline tracing.
4. Obtain rest SpO2, HR, BP, symptoms.
5. Start warm-up/stage 1; advance stages only when signals are adequate and patient is safe.
6. Speak briefly at stage transitions; do not distract with continuous chatter that masks symptoms.
7. At stop, begin protocol recovery; continue monitoring until stable toward baseline.
8. Document peak work, reason for stopping, peak HR/SpO2/BP, arrhythmias, and recovery course.

Absolute vs relative stop criteria (high-level)

Exact lists live in exercise testing guidelines and institutional SOPs. For RPFT exam thinking, separate:

Absolute stop concepts (stop immediately—do not “finish the stage”):

• Signs of severe ischemia or acute coronary syndrome symptoms as defined by protocol (e.g., increasing angina with ECG changes when ECG is monitored)
• Sustained dangerous arrhythmias or high-grade blocks per policy
• Signs of poor perfusion (near-syncope, confusion, cold clammy skin)
• Technical inability to monitor a patient who needs monitoring (e.g., complete ECG loss in a high-risk test when policy requires ECG)
• Patient request when linked to severe symptoms; always err toward safety
• Severe desaturation or other thresholds set by medical direction

Relative stop concepts (consider stopping; physician/protocol judgment):

• Progressive chest pain without full absolute criteria yet
• Exaggerated hypertensive response beyond policy limits
• Increasing arrhythmia burden that is not yet “absolute”
• Worsening wheeze/bronchospasm, severe dyspnea out of proportion
• Equipment problems that degrade data quality mid-test
• Leg pain/claudication that will only worsen without diagnostic gain

You are not expected to invent numeric cutoffs the NBRC has not published as exam-specific constants. You are expected to recognize that falling systolic BP with progressive work, malignant-appearing rhythms, severe chest pain, and neurologic symptoms are stop—not “coach through it”—events.

Role of the PFT Technologist vs Full CPET Lab Scope

Key exam message: Monitored exercise without gas exchange still requires rigorous safety and data quality. Full CPET adds breath-by-breath gas exchange and advanced interpretation (cardiac vs pulmonary limitation patterns). Do not claim a simple treadmill walk with SpO2 “measured VO2max.” Conversely, do not underplay monitoring: a “simple” exercise desaturation study can still precipitate arrhythmia or severe hypoxemia.

Validity (II.C.13.b)

Reject, repeat, or qualify when:

A valid report states protocol, mode, peak work, reason for termination, key vitals, SpO2 nadir, ECG events (if monitored), and limitations.

Clinical Scenario

Order: monitored cycle exercise with continuous SpO2 and ECG for a 55-year-old with COPD and atypical chest tightness—submaximal desaturation and rhythm screen, not full CPET. You select cycle because of knee OA and fear of treadmill (II.A.13.b). After electrode prep and rest baselines, you advance watt stages every 2 minutes per SOP, measure BP each stage, and watch ECG. At moderate watts SpO2 falls to 87% with readable oximeter waveform; patient reports severe dyspnea without chest pain; BP is stable. You stop for desaturation/symptom criteria, recover with supplemental O2 per protocol, document peak watts and nadir SpO2, and note no ischemic ECG changes were seen by the covering policy pathway (II.B.13.b). Validity: workload calibrated, ECG readable, SpO2 quality acceptable—study usable for clinical follow-up (II.C.13.b). You do not report a VO2max or anaerobic threshold without metabolic cart data.

Link to Practice

/practice/rpftPractice questions with detailed explanations